Ligand validation:6GD7

EVB: sulfonato-calix[8]arene

EVB is a Ligand Of Interest in 6GD7 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GD7_EVB_A_202	96%	24%	0.065	0.975	2	1.11	8	10	0	0	100%	1
6GD6_EVB_A_202	90%	30%	0.086	0.968	1.71	1.11	9	10	0	0	100%	1
6GD8_EVB_A_202	85%	22%	0.112	0.977	2.25	1	8	10	1	0	100%	1
6RSK_EVB_A_202	74%	27%	0.152	0.983	2.07	0.93	28	5	0	0	100%	1
6GD9_EVB_A_203	67%	24%	0.166	0.976	2.21	0.91	8	3	0	0	100%	1
6RSJ_EVB_A_202	60%	28%	0.19	0.978	2.07	0.84	30	3	0	0	100%	1
7ALF_EVB_A_101	100%	94%	0.045	0.987	0.25	0.2	-	-	0	0	100%	1
6Z5Q_EVB_B_101	99%	94%	0.053	0.987	0.24	0.19	-	-	0	0	100%	1
7ALG_EVB_B_101	99%	94%	0.055	0.986	0.26	0.18	-	-	0	0	100%	1
6Z5P_EVB_A_101	95%	91%	0.068	0.974	0.3	0.29	-	-	0	0	100%	1
8C9Y_EVB_A_101	94%	93%	0.079	0.978	0.28	0.22	-	-	0	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.